Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

OBJECTIVES: The impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood. METHODS: Retrospective study on 31 patients having undergone 36 CRS-HIPEC at a single institution (safety-net hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Chokshi, Ravi J., Kim, Jin K., Patel, Jimmy, Oliver, Joseph B., Mahmoud, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746885/
https://www.ncbi.nlm.nih.gov/pubmed/33364338
http://dx.doi.org/10.1515/pp-2020-0105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746885/
https://www.ncbi.nlm.nih.gov/pubmed/33364338
http://dx.doi.org/10.1515/pp-2020-0105

Ejemplares similares